New Immune Therapy Successfully Treats Brain Tumors in Mice Dec. 17, 2012
Using an artificial protein that stimulates the body’s natural immune system to fight cancer, a research team at Duke Medicine has engineered a lethal weapon that kills brain tumors in mice while sparing other tissue. If it can be shown to work in humans, it would overcome a major obstacle that has hampered the effectiveness of immune-based therapies.
Duke Raleigh Hospital Names New President Dec. 4, 2012
Rick Gannotta, NP, DHA, FACHE, has been named president of Duke Raleigh Hospital, effective Jan. 1, 2013. He has served as the chief operating officer of Duke Raleigh since 2006, overseeing the hospital’s operations, nursing and clinical activities, and financial outcomes.
Duke School of Nursing and Winston-Salem State Partner to Increase Minority PhD Candidates Nov. 30, 2012
The Duke University School of Nursing and Winston-Salem State University (WSSU) have received a $1.245 million, five-year grant from the National Institutes of Health to increase the number of underrepresented WSSU minority nursing students who are prepared to transition to PhD programs in nursing, and other related biomedical/behavioral science disciplines at Duke University.
Duke University Health System Hospitals Awarded “A” for Hospital Safety Nov. 28, 2012
The three hospitals in the Duke University Health System – Duke University Hospital, Durham Regional and Duke Raleigh – each received an “A” Hospital Safety Score by The Leapfrog Group, an independent national nonprofit run by employers and other large purchasers of health benefits.